- Home
- TNGX vs BNTC Comparison
TNGX vs BNTC Comparison
Compare TNGX & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- BNTC
- Stock Information
- Founded
- TNGX 2014
- BNTC 1995
- Country
- TNGX United States
- BNTC United States
- Employees
- TNGX N/A
- BNTC N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- TNGX Health Care
- BNTC Health Care
- Exchange
- TNGX Nasdaq
- BNTC Nasdaq
- Market Cap
- TNGX 317.4M
- BNTC 352.5M
- IPO Year
- TNGX N/A
- BNTC N/A
- Fundamental
- Price
- TNGX $1.14
- BNTC $13.63
- Analyst Decision
- TNGX Strong Buy
- BNTC Strong Buy
- Analyst Count
- TNGX 7
- BNTC 7
- Target Price
- TNGX $12.33
- BNTC $24.71
- AVG Volume (30 Days)
- TNGX 532.3K
- BNTC 34.2K
- Earning Date
- TNGX 05-12-2025
- BNTC 05-16-2025
- Dividend Yield
- TNGX N/A
- BNTC N/A
- EPS Growth
- TNGX N/A
- BNTC N/A
- EPS
- TNGX N/A
- BNTC N/A
- Revenue
- TNGX $42,069,000.00
- BNTC N/A
- Revenue This Year
- TNGX N/A
- BNTC N/A
- Revenue Next Year
- TNGX N/A
- BNTC N/A
- P/E Ratio
- TNGX N/A
- BNTC N/A
- Revenue Growth
- TNGX 15.17
- BNTC N/A
- 52 Week Low
- TNGX $1.11
- BNTC $5.74
- 52 Week High
- TNGX $12.02
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- TNGX 36.06
- BNTC 49.98
- Support Level
- TNGX $1.03
- BNTC $13.35
- Resistance Level
- TNGX $1.56
- BNTC $15.69
- Average True Range (ATR)
- TNGX 0.15
- BNTC 0.74
- MACD
- TNGX -0.01
- BNTC -0.03
- Stochastic Oscillator
- TNGX 17.74
- BNTC 20.46
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.